Your browser doesn't support javascript.
loading
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Mitchell, Jennifer M; Ot'alora G, Marcela; van der Kolk, Bessel; Shannon, Scott; Bogenschutz, Michael; Gelfand, Yevgeniy; Paleos, Casey; Nicholas, Christopher R; Quevedo, Sylvestre; Balliett, Brooke; Hamilton, Scott; Mithoefer, Michael; Kleiman, Sarah; Parker-Guilbert, Kelly; Tzarfaty, Keren; Harrison, Charlotte; de Boer, Alberdina; Doblin, Rick; Yazar-Klosinski, Berra.
Afiliación
  • Mitchell JM; Neuroscape, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.
  • Ot'alora G M; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.
  • van der Kolk B; Department of Veterans Affairs, Research Service, San Francisco VA Medical Center, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.
  • Shannon S; Aguazul-Bluewater, Inc., Boulder, CO, USA.
  • Bogenschutz M; Boston University School of Medicine, Boston, MA, USA.
  • Gelfand Y; Wholeness Center, Fort Collins, CO, USA.
  • Paleos C; Department of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.
  • Nicholas CR; Zen Therapeutic Solutions, Mt. Pleasant, SC, USA.
  • Quevedo S; Nautilus Sanctuary, New York, NY, USA.
  • Balliett B; Department of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Hamilton S; Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.
  • Mithoefer M; San Francisco Insight and Integration Center, San Francisco, CA, USA.
  • Kleiman S; New School Research, LLC, Los Angeles, CA, USA.
  • Parker-Guilbert K; MAPS Public Benefit Corporation, San Jose, CA, USA.
  • Tzarfaty K; Medical University of South Carolina, Charleston, SC, USA.
  • Harrison C; Kleiman Consulting and Psychological Services, PC, Ivyland, PA, USA.
  • de Boer A; KPG Psychological Services, LLC, Brunswick, ME, USA.
  • Doblin R; University of Haifa, Haifa, Israel.
  • Yazar-Klosinski B; MAPS Israel, Hod Hasharon, Israel.
Nat Med ; 29(10): 2473-2480, 2023 10.
Article en En | MEDLINE | ID: mdl-37709999
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos por Estrés Postraumático / N-Metil-3,4-metilenodioxianfetamina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trastornos por Estrés Postraumático / N-Metil-3,4-metilenodioxianfetamina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos